These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23831838)

  • 1. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics.
    Staud F; Cerveny L; Ahmadimoghaddam D; Ceckova M
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2007-11. PubMed ID: 23831838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.
    Yonezawa A; Inui K
    Br J Pharmacol; 2011 Dec; 164(7):1817-25. PubMed ID: 21457222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
    Nies AT; Koepsell H; Damme K; Schwab M
    Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
    Motohashi H; Inui K
    AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
    Motohashi H; Inui K
    Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs.
    Nies AT; Damme K; Schaeffeler E; Schwab M
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1565-77. PubMed ID: 22970772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.
    Nies AT; Damme K; Kruck S; Schaeffeler E; Schwab M
    Arch Toxicol; 2016 Jul; 90(7):1555-84. PubMed ID: 27165417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
    Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F
    PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats.
    Ailabouni AS; Mettu VS; Thakur A; Singh DK; Prasad B
    Drug Metab Dispos; 2024 Jan; 52(2):86-94. PubMed ID: 38049999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
    Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H
    Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K; Apáti S; Sakata T; Homma M
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties.
    Pelis RM; Wright SH
    Curr Top Membr; 2014; 73():233-61. PubMed ID: 24745985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
    Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
    Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.
    Koepsell H; Lips K; Volk C
    Pharm Res; 2007 Jul; 24(7):1227-51. PubMed ID: 17473959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Experimental Conditions on the Evaluation of Interactions between Multidrug and Toxin Extrusion Proteins and Candidate Drugs.
    Lechner C; Ishiguro N; Fukuhara A; Shimizu H; Ohtsu N; Takatani M; Nishiyama K; Washio I; Yamamura N; Kusuhara H
    Drug Metab Dispos; 2016 Aug; 44(8):1381-9. PubMed ID: 27271370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first characterization of multidrug and toxin extrusion (MATE/SLC47) proteins in zebrafish (Danio rerio).
    Lončar J; Popović M; Krznar P; Zaja R; Smital T
    Sci Rep; 2016 Jun; 6():28937. PubMed ID: 27357367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.
    Kato K; Mori H; Kito T; Yokochi M; Ito S; Inoue K; Yonezawa A; Katsura T; Kumagai Y; Yuasa H; Moriyama Y; Inui K; Kusuhara H; Sugiyama Y
    Pharm Res; 2014 Jan; 31(1):136-47. PubMed ID: 23907530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.